GenMont Biotech Incorporation (TPE:3164)
Taiwan · Delayed Price · Currency is TWD 17.95
-0.05 (-0.28%)
Mar 4, 2026, 1:35 PM CST
TPE:3164 Market Cap
TPE:3164 has a market cap or net worth of 1.54 billion as of March 3, 2026. Its market cap has decreased by -10.99% in one year.
Market Cap
1.54B
Enterprise Value
1.45B
Revenue
391.48M
Ranking
n/a
PE Ratio
46.03
Stock Price
17.95
Market Cap Chart
Since May 8, 2006, TPE:3164's market cap has increased from 899.18M to 1.54B, an increase of 71.70%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.54B | -2.18% |
| Dec 31, 2025 | 1.58B | -9.68% |
| Dec 31, 2024 | 1.75B | -18.22% |
| Dec 29, 2023 | 2.14B | 4.39% |
| Dec 30, 2022 | 2.05B | -2.67% |
| Dec 30, 2021 | 2.10B | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TaiRx | 2.11B |
| Chunghwa Chemical Synthesis & Biotech | 2.08B |
| Advagene Biopharma | 1.96B |
| Genomics BioSci & Tech. | 1.79B |
| Great Novel Therapeutics Biotech & Medicals | 1.52B |
| Abnova (Taiwan) | 1.52B |
| NeoCore Technology | 1.50B |
| Meribank Biotech | 1.32B |